• Ülevaade
  • Rasvumise levimus
  • Kaasnevad haigused
  • Strateegiad
Info laeb. Palun oodake!

Rasvumise levimus

Täiskasvanud, 2007-2008

Uuringu tüüp:Mõõdetud
Vanus:15+
Valimi suurus:601
Hõlmatud piirkond:Riiklik
Viited:Daigre J-L, et al. The prevalence of overweight and obesity, and distribution of waist circumference, in adults and children in the French Overseas Territories: The PODIUM survey. Diabetes Metab (2012), http://dx.doi.org/10.1016/j.diabet.2012.03.008
Märkused:Small sample size
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Lapsed, 2003

Uuringu tüüp:Mõõdetud
Vanus:5-6
Valimi suurus:5287
Hõlmatud piirkond:Riiklik
Viited:J.-L. Daigre, A. Atallah, J.-L. Boissin, G. Jean-Baptiste, P. Kangambega, H. Chevalier, B. Balkau, D. Smadja, J. Inamo, The prevalence of overweight and obesity, and distribution of waist circumference, in adults and children in the French Overseas Territories: The PODIUM survey, Diabetes & Metabolism,Volume 38, Issue 5,2012,Pages 404-411,ISSN 1262-3636, https://doi.org/10.1016/j.diabet.2012.03.008https://www.sciencedirect.com/science/article/abs/pii/S1262363612000754?via%3Dihub (last accessed 09.05.2022)

Söögitoruvähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000

Mehed, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Rinnavähk

Naised, 2022

Vanus:20
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Pärasoolevähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Mehed, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Kõhunäärmevähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Mehed, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Sapipõie vähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000

Mehed, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Neeruvähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Mehed, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Emakavähk

Naised, 2022

Vanus:20+
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2020

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2143
Mõisted:Age-standardized indicence rates per 100 000

Diabeedi levimus

Täiskasvanud, 2017

Viited:Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org
Mõisted:Diabetes age-adjusted comparative prevalence (%).

Ovarian Cancer

Naised, 2022

Vanus:20+
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Leukemia

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Leukemia

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Liver and intrahepatic bile duct Cancer

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Multiple Myeloma

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Non Hodgkin Lymphoma

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Thyroid Cancer

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Policies, Interventions and Actions

Specialised Obesity Centres (CSOs)

Specialised obesity care centres (CSOs) are responsible for providing multidisciplinary care for people with severe and/or complex obesity. There are 37 CSOs located in mainland France and overseas (Guadeloupe, La Réunion and Martinique) attached to public and private healthcare institutions.

Categories:Evidence of Multidisciplinary Intervention
Year(s):2023 (ongoing)
Target age group:Täiskasvanud ja lapsed
Organisation:Ministry of Health and Prevention
Find out more:sante.gouv.fr
Linked document:Download linked document

4th National Nutrition and Health Program (PNNS 4): Overseas

This plan adapts the French National Nutrition and Health Program (PNNS) for the specific territorial characteristics of French overseas territories. It aims to improve population health through diet and physical activity, and reduce social inequalities in health. Key actions include promoting sustainable access to healthy food for disadvantaged groups, improving the food and physical environment to be more conducive to health, raising awareness of new nutritional recommendations, and continuing research to improve knowledge.

Categories:Evidence of Nutritional or Health Strategy/Guidelines/Policy/Action plan
Categories (partial):Evidence of National Obesity Strategy/Policy or Action plan
Year(s):2019-2023
Target age group:Täiskasvanud ja lapsed
Organisation:Ministry of Health and Prevention, France
Find out more:sante.gouv.fr
Linked document:Download linked document

No actions could be found for the above criteria.

Feedback

Are you finding the information on these pages useful?
Yes
No
N/A

Thank you for feeding back to World Obesity.

If you have any further feedback or suggestions please email us at obesity@worldobesity.org.

Close
Loading